Cargando…

A role for statin therapy in Alzheimer's disease

Detalles Bibliográficos
Autor principal:	Richards, David
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026263/ http://dx.doi.org/10.1186/gb-2010-11-s1-p33

Ejemplares similares

A237 STATIN USE IN LIVER TRANSPLANT: INDICATION, USE, AND IMPACT OF STATIN THERAPY ON PATIENT OUTCOMES
por: Smith, M K, et al.
Publicado: (2023)

Statin anti-inflammatory therapy in septic patients
por: González, Celso Montoya, et al.
Publicado: (2008)

Aspirin and statin therapy in sepsis, a red herring?
por: Campbell, R, et al.
Publicado: (2015)

Statin therapy in patients admitted to hospital with presumed infection
por: Kruger, P, et al.
Publicado: (2009)

The effect of statin therapy on the characteristics of coronary artery disease in patients with acute coronary syndrome
por: Gulin, D, et al.
Publicado: (2013)

Statin therapy on admission to intensive care and outcome: an observational cohort study
por: Mackay, A, et al.
Publicado: (2010)

The implications of statin induced peripheral neuropathy
por: West, Brenton
Publicado: (2011)

Association of prior statin therapy with cytokine profiles and outcomes in patients hospitalized with community acquired pneumonia
por: Milbrandt, E, et al.
Publicado: (2005)

10. Warning: statin-induced autoimmune necrotising myositis
por: Jasim, Muhamad, et al.
Publicado: (2019)

0737. Statins protect the vasculature from excessive angpt-2 production in sepsis
por: Thamm, K, et al.
Publicado: (2014)

Effects of statins on mitochondrial respiration and outcome during experimental sepsis
por: Morel, J, et al.
Publicado: (2012)

A meta-analysis of randomized controlled trials on the use of statins in septic patients
por: Landoni, G, et al.
Publicado: (2014)

Evaluation of chronic statin treatment on sepsis outcome in I.C.U
por: Youssef, HAA, et al.
Publicado: (2015)

Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?
por: Khanna, A, et al.
Publicado: (2011)

Effects of statins on postoperative sepsis, systemic inflammatory response syndrome and mortality after colorectal surgery
por: Khan, A, et al.
Publicado: (2009)

Evaluate the effects of statins on myocardial remodeling in ApoE-/- mice at 3T cardiac magnetic resonance
por: Zhang, Huan, et al.
Publicado: (2015)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

Relationship between preoperative statins use and atrial fibrillation (AF) after cardiac surgery. analysis with a propensity score
por: Fernandez-Zamora, M, et al.
Publicado: (2015)

Investigating the effects of beta-amyloid on hippocampal signalling in Alzheimer's disease
por: Warburton, Julia M, et al.
Publicado: (2015)

Role of the infectious disease consultant in improving antimicrobial therapy prescription in neurosurgery
por: Pagani, L, et al.
Publicado: (2011)

Sensitivity analysis to explain the excitability in a pyramidal neuron with application to Alzheimer’s disease
por: Nowacki, Jakub, et al.
Publicado: (2011)

DIFFERENTIAL EFFECTS OF STATINS ON COGNITION IN WOMEN AT RISK FOR ALZHEIMER’S DISEASE
por: Wroolie, Tonita E, et al.
Publicado: (2019)

RNA-Seq analysis of two brain regions vulnerable to Alzheimer's disease
por: Wang, Xinkun
Publicado: (2012)

Combining computational neuroscience and body sensor networks to investigate Alzheimer’s disease
por: Bergmann, Jeroen, et al.
Publicado: (2012)

Effect of Alzheimer's disease on the dynamical and computational characteristics of recurrent neural networks
por: Bachmann, Claudia, et al.
Publicado: (2013)

Regulation of key proteins in Alzheimer’s disease molecular pathogenesis by ubiquilin-1
por: Takalo, Mari, et al.
Publicado: (2013)

Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease
por: Segatto, Marco, et al.
Publicado: (2013)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease
por: Tayubi, Iftikhar Aslam, et al.
Publicado: (2014)

Alterations in choroid plexus gene expression in Alzheimer’s disease provide inferences for CSF composition and dynamics
por: Miller, Miles C, et al.
Publicado: (2010)

A model study for the progressive disruption of CA1 firing properties during Alzheimer’s disease
por: Culmone, Viviana, et al.
Publicado: (2011)

β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer’s disease
por: Thathiah, Amantha, et al.
Publicado: (2013)

FcgRIIb mediates amyloid-β neurotoxicity and memory impairment in a model of Alzheimer’s disease
por: Jung, Yong-Keun
Publicado: (2013)

Distribution of amyloid burden is different between idiopathic normal pressure hydrocephalus and Alzheimer's disease
por: Tokuda, Takahiko, et al.
Publicado: (2015)

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020)

Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease
por: Dopheide, J, et al.
Publicado: (2020)

Amyloid-β drives a type-1 interferon mediated neuro-inflammatory response in Alzheimer’s disease
por: Minter, Myles, et al.
Publicado: (2013)

Development of a paradigm to investigate mechanisms of divided and selective attention impairment in the rodent models of Alzheimer’s disease
por: Baranauskas, Gytis, et al.
Publicado: (2013)

An intronic rare mutation in Presenilin-1 (PSEN-1) gene may be involved in the developement of Alzheimer’s disease
por: Bhaumik, Pranami, et al.
Publicado: (2014)

Aneuploidy-driven non-heritable genomic variations demonstrate area-specific distribution in the Alzheimer’s disease brain
por: lourov, Ivan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d0pjkgpdvngf62kmvivq837i7o